Portfolio
Strategy
Team
News
Careers
Contact
Investor Login
Portfolio
Strategy
Team
News
Careers
Contact
Artiva Biotherapeutics Announces First Patient Dosed in Phase 1 Trial of AlloNK® Cell Therapy Candidate in Lupus Nephritis
Read Article
News
2024
2023
Archive
Search news articles
February 24, 2021
Pear Therapeutics Announces Publication of Economic Analysis Showing Cost-Effectiveness of reSET-O in Treating Opioid Use Disorder
February 24, 2021
scPharmaceuticals Inc. Announces Results of Type A End-of-Review Meeting with FDA Regarding FUROSCIX® NDA
February 22, 2021
IDEAYA Biosciences Announces Inaugural Synthetic Lethality Investor Day
February 17, 2021
scPharmaceuticals Inc. Appoints Renowned Heart Failure Specialist William T. Abraham, M.D., to its Board of Directors
February 17, 2021
Pear Announces Indiana Family and Social Services Administration Division of Mental Health and Addiction Will Provide Access to Prescription Digital Therapeutics for Substance Use and Opioid Use Disorders
February 17, 2021
IDEAYA Biosciences Appoints Susan L. Kelley, M.D., an Industry Veteran in Medical Oncology and Clinical Development, to its Board of Directors
February 17, 2021
Cidara Therapeutics Announces New Data for Rezafungin at the 21st ICHS Symposium
February 11, 2021
Cidara Therapeutics to Present New Data for Rezafungin and Influenza AVCs at the 21st ICHS Symposium
February 11, 2021
Ensoma Announces Strategic Collaboration with Takeda to Accelerate Next-Generation In Vivo Gene Therapies
February 11, 2021
Ensoma Launches to Pioneer Next-Generation In Vivo Approach to Deliver First “Off-the-shelf” Genomic Medicines
« Previous Page
1
…
42
43
44
45
46
…
118
Next Page »